Back
Prelude Therapeutics, Inc. Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
45
PRLD
Prelude Therapeutics, Inc.
Last Price:
$1.90
Seasonality Move:
-23.7%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.
Prelude Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.98 | Sell |
| 20-day SMA: | 2.33 | Sell |
| 50-day SMA: | 1.97 | Sell |
| 200-day SMA: | 1.29 | Buy |
| 8-day EMA: | 0.44 | Buy |
| 20-day EMA: | 0.19 | Buy |
| 50-day EMA: | 0.08 | Buy |
| 200-day EMA: | 0.02 | Buy |
Prelude Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 45.62 | Sell |
| Chaikin Money Flow: | -96875 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Prelude Therapeutics, Inc. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Prelude Therapeutics, Inc. Stock
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 1.97 while PRLD 8-day simple moving average is 1.98, which is a Sell signal.
-
The stock price of PRLD is 1.97 while Prelude Therapeutics, Inc. 20-day SMA is 2.33, which makes it a Sell.
-
Prelude Therapeutics, Inc. 50-day simple moving average is 1.97 while PRLD share price is 1.97, making it a Sell technically.
-
PRLD stock price is 1.97 and Prelude Therapeutics, Inc. 200-day simple moving average is 1.29, creating a Buy signal.
PRLD Technical Analysis vs Fundamental Analysis
Sell
45
Prelude Therapeutics, Inc. (PRLD)
is a Sell
Is Prelude Therapeutics, Inc. a Buy or a Sell?
-
Prelude Therapeutics, Inc. stock is rated a SellThe current Prelude Therapeutics, Inc. [PRLD] share price is $1.97. The Score for PRLD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Prelude Therapeutics, Inc. Stock Info
Market Cap:
123.8M
Price in USD:
1.97
Share Volume:
96.9K
Prelude Therapeutics, Inc. 52-Week Range
52-Week High:
4.22
52-Week Low:
0.61
Sell
45
Prelude Therapeutics, Inc. (PRLD)
is a Sell
Prelude Therapeutics, Inc. Share Price Forecast
-
What is the Prelude Therapeutics, Inc. stock price today?The Prelude Therapeutics, Inc. stock price is 1.97 USD today.
-
Will PRLD stock go up or go down?Prelude Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Prelude Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Prelude Therapeutics, Inc. is overvalued.
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 1.97 while PRLD 8-day exponential moving average is 0.44, which is a Buy signal.
-
The stock price of PRLD is 1.97 while Prelude Therapeutics, Inc. 20-day EMA is 0.19, which makes it a Buy.
-
Prelude Therapeutics, Inc. 50-day exponential moving average is 0.08 while PRLD share price is 1.97, making it a Buy technically.
-
PRLD stock price is 1.97 and Prelude Therapeutics, Inc. 200-day simple moving average is 0.02, creating a Buy signal.
Fundamental Analysis of Prelude Therapeutics, Inc.
Is Prelude Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Prelude Therapeutics, Inc.
Should I short Prelude Therapeutics, Inc. stock?
-
PRLD Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Prelude Therapeutics, Inc. is a Buy
-
Prelude Therapeutics, Inc. Relative Strength Index (RSI) is 45.62, which suggest Prelude Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Prelude Therapeutics, Inc. is ( - ), which suggest Prelude Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Prelude Therapeutics, Inc. is ( - ), which suggest Prelude Therapeutics, Inc. is a Buy
* Prelude Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.